HELIOS MUTUAL FUND LAUNCHES " HELIOS BALANCED ADVANTAGE FUND" (BAF).

Helios Mutual Fund announced the launch of Helios Balanced Advantage Fund (BAF),an open ended dynamic asset allocation fund.This NFO will open for subscription on March,11,2024 & Close on March 20,2024.This fund aims to capitalize on the potential upside of eauities while attempting to limit the downside through dynamic portfolio management.This will be done by investing in equity & equity related instruments and active use of debt,money market instruments & derivatives.The equity portfolio will be built on basis "Helio's Elimination Investing" philosophy-based on eight fundamental  screening factors that have repeatedly proven to be effective in weeding out poor performers,gravitating towards winners,and creating a sustainable outperformance profile.

The investment strategy will be to normally maintain gross equity and equity related exposure between 65% -100% and the net equity exposure between 30% to 80%.Various derivative strategies would be used for hedging against market headwinds. Addressing the media Mr. Sameer Arora,the main Founder &Fund Manager  of Helios Capital said," Why the investor should invest in Helios Balanced Advantage Fund: Mr.Samir Arora has an investing experience of 29 years.

   Growth Potential with balanced allocation.

   Attempts to limit downside risk by hedging,tweaking debt.

  Endeavors to allocate =/> 65% into equities,which will provide the scheme with equity fund taxation.

  Units can be redeemed on any Business Day at NAV based price.

  Risk mitigation & rigorous screening.

  Fund Managers with more than 25 years of combined Experience .

Consistency & Disciplined investing.

The Minimum Application amount will be Rs.5000/- & in multiples of Re.1 thereafter.

Please Note: Mutual Fund investments are subject to market risks,read all scheme related documents carefully.

                                                     

                                                 * 

 

THE FEDERATION OF INDIAN GRANITE AND STONE INDUSTRY ELECTED NEW PRESIDENT & GENERAL SECRETARY FOR THE TERM 2024-2026.

 The Federation of Indian Granite and Stone Industry (FIGSI) announced the election of Mr.S.Krishna Prasad as President and Mr.Manoj Kumar Singh as the General Secretary for the term 2024-2026.FIGSI is actively involved in the development of the natural stone & Granite industry. FIGSI also organises trhe STONA exhibition every Two Years. The President, Mr.S.Krishna Prasad,is the Managing Director of M/s Prasad Granites with a legacy of spanning over 50 years. Mr.Manoj Kumar Singh is the Director of M/s Metro Granites & Marbles & ManagingPartner of M/s Metro stones with its operations in more than 40 countries.

The next  STONA 2025 & 16th International Granite & Stone Fair  will be held in Bengaluru at Bangalore International Exhibition Centre (BIEC) from 12th TO 15th February,2025.

Mr.S.Krishna Prasad,President expressed his vision as follows"My primary goal shall be to actively engage for increased visibility and branding of  our Federation while upholding the values that define us.Togetherness and interdependence would be the key words in my journey and as President".He also said that there should be a policy for Waste Disposal . He also said that Karnataka's policy is encouraging for the industry. FIGSI also set up
Two Skill Development Centres in Hosur (Tamilnadu) and in Jaipur (Rajasthan).

RELENTO ANNOUNCES STRATEGIC GLOBAL EXPANSION & LAUNCH OF AI-FIRST LAB & ' RELENTO CARES INITIATIVE'

 RELENTO, a global leader in AI driven business advisory& consulting services,announced a key milestone in their growth story with the launch of AI-First Lab,a global innovation & incubator Hub,at its new state-of-the-art office at IBC Knowledge Park in Bengaluru,Karnataka.The Company also unveiled its Relento Cares inititiative,a community service engagement program focused on uplifting local under privileged & underserved communities across the globe by bridging the digital divide.Through the launch of  Relento cares Initiative,the Company has pledged 1 Million USD towards this global community service initiative.As part of the Relento Cares Initiative, the Company is committed  towards building & equipping a new computer Lab along with additional class rooms at Neraluru Government School with an aim to support Local Bengaluru Community says Mr.Venkatesh Kodangal,Chief Strategy Officer.

" our AI Lab provides a dual purpose platform that supports real world applications and acts as a collaborative hub to nurture innovation.It serves as a beacon for academic institutions across the globe"says Mr.T.P.Vincent,Chief Technology Officer.

Mr.Rajan Gaur,CEO,Relento said, " As part of our global expansion strategy,this new office and AI Innovation Lab in Bengaluru will be a catalyst for our next phase of growth & support our mission to build an AI - first world in collaboration with our customers and partners."

TATA CONSULTANCY SERVICES (TCS) WORLD 10K BENGALURU ON SUNDAY,28,APRIL,2024. CALLED ENDENDIGU BENGALURU-FOREVER BENGALURU.

Procam International, pioneers of the distance running movement  in India  announced the 16th edition of the World Athletics Gold Label Road Race TCS World 10K Bengaluru scheduled on Sunday,28th April,2024from new venue i.e Field Marshal Sam Manekshaw Parade Ground .The World's Premier 10K with a total Prize money of USD 2,10,000,attracts some of the leading Indian& International athletes along with  amateur runners from across the globe.Registration for all races commence on Thursday,15th February at 07.00 AM & will conclude onFriday,29th March,at 11.59 PM as soon as running places are filled ,whichever is earlier.Register now at : https://tcsworld10k.procam.in.To encourage women's participation,a limited number of spots are set aside for women who donot possess a timing certificate.Registration under these criteria will be based on a first come,first served basis.

APOLLO CANCER CENTRES (ACC)- FIRST PRIVATE HOSPITAL IN INDIA TO SUCCESSFULLY COMPLETE CarTCELL THERAPY - NOW INTRODUCES " MADE IN INDIA",CAR T CELL PROGRAM.

Apollo Cancer Centre (ACC),successfully complete CAR-T cell program and to further augment it,the hospital group will now provide access "Made In India" CAR-T cell therapy.CAR-T cell therapies,often known as ""Living Drugs' involve the extraction of a patient's T-Cells (a type of white blood cells whose function is to fight cancer cells,through a process known as Aphersis.These T-Cells are then genetically modified by a safe vehicle (Viral Vector) in a controlled laboratory setting,so that they express modified connectors on their surface called Chimeric Antigen Receptors (CAR's).These CAR's are specifically designed to recognise a protein which is abnormally expressed on certain cancer cells.They are then multiplied to a desired dose,and infused directly into the patient.

CAR-T cell therapies have gained global recogntion for their unparalleled success in transforming the lives of patients with challenging B-cell malignancies. Over 25,000 patients have benefitted worldwide from this therapeutic model.

Dr.Aditya Murali,Senior consultant - Medical & Haemato Oncology,ACC,Bangalore ,sharing insights into the success of the program,he said"having successfully treated patients with imported drugs,we are now poised to treat them with indigenously built therapy".

Dr.Neema Bhat,Consultant- Haematology & Paediatric Oncology,ACC,Bangalore said,"This milestone signifies a new chapter in our fight against cancer,offering renewed hope &possibilities to those battling these conditions".

On this occassion,Mr.Dinesh Madhavan,President,Group Oncology & International,Apollo Hospitals Enterprises Limited,said,"The indigenously built CAR-T treatment,NexCAR19 reflects our commitment to provide transformative & cutting edge cancer care.Apollo Cancer Centres is not just changing the narrative,we are rewriting the possibilities of giving better treatment outcome for cancer patients across India & beyond'.

Dr.Manish Mattoo,CEO,Karnataka region,Apollo Hospitals, said," we are proud to be the first in India to achieve the milestone of groundbreaking success in CAR-T cell Therapy & this achievement reflects our dedication to pushing healthcare boundaries & delivering impactful solutions to the community".

In a layman's language,CAR-T cell therapy  reprogramme the body's immunity by harnessing the resources of the  body of the patient to fight by using the body's immunity.This treatment is mainly used for blood cancer Now.

ASTER CMI HOSPITAL UNVEILS A PATH BREAKING INNOVATION IN AI - ENDOWMENT TO THE FUTURE OF HEALTH CARE.

 Aster CMI Hospital,charges ahead as a Health care patron with its groundbreaking innovative technology, which supports the health experts on various aspects of treatment such as analyzing vast amounts of data that could lead to accurate diagnosis of diseases earlier,developing new treatment options, and immediate monitoring of vitals for various specialties. 

AI Carpal Tunnel Syndrome (CTS) is one such technology that is developed by the neurology department  which is poised to revolutionize nerve ultra sound diagnostics. This technology redfines,diagnoses and screens efficiently.It can identify the median nerve in ultra sound videos and detect CTS with the highest accuracy (95%)making a significant leap in health care innovation.The AI tool signifies a transformative stride towards precision and efficiency in CTS diagnostics,marking a new era in healthcare.

Mr.Ramesh Kumar.S.CEO,Aster Hospitals said," The hospital has been at the forefront,seamlessly weaving human expertise with AI to usher in a new era in healthcare excellence and actively engaging in collaborative efforts with providers,researchers and innovators to unlock the full potential of AI for the greater good of humanity".

Commenting on the occasion,Dr.Lokesh Bathala,Lead Consultant Neurology, said," This Lab is an exemplification to the unlimited potential of AI in Health Care.These AI tools can prevent long term complications & improve the quality of life.It can also minimize the need for repetetive examinations and invasive procedures,reducing patient's discomfort and anxiety.While the AI tools significantly reduce the inference time,it is important to note that the final diagnosis will always be carried out by the physician". This transformative technology -enabled tool marks new dawn in health care says       Dr.Nitish Shetty, DM Healthcare.

Dr.Phanindra,from  Indian Institute of Science who has set up the Lab at the Hospital said,: It is just the beginning & AI redefines diagnosis & screening"

KARNATAKA BANK AND CLIX CAPITAL ENTER INTO CO-LENDING PARTNERSHIP THROUGH YUBI PLATFORM.

Karnataka Bank Ltd.,a leading Private sector Bank and Clix Capital,one of India's fastest growing new age NBFC's have entered into a strategic digital co-lending partnership through Yubi Co.lend platform.This partnership is focused on providing loans to the Indian MSME sector which is one of the biggest contributors to India's GDP and employment growth.The agreement is in line with the Reserve Bank Of India's guidelines and co-lending by banks and NBFC's to priority sectors.  

This partnership combines Karnataka Bank's low cost of funds end to end digital capabilities & expertise to offer credit facilities to this segment along with Clix Capital's strong & easy lending platform and robust due diligence.The partnership aims to provide seamless fencing solutions, conveniently and economically in digital manner,thereby enabling both the partners to draw upon each other's strengths to serve the unserved.The agreement was signed in Bengaluru today.

Speaking on the collaboration,Mr.Srikrishnan H, Managing Director &CEO,Karnataka Bank said,"By this arrangement,the much needed liquidity at affordable rates for the MSME sector will be a reality.Clix Capital & Karnataka Bank will jointly address the MSME's requirements adding impetus to the micro credit facilities to this segment keeping in mind the sustainable economic growth for the country".

Mr.Rakesh Kaul,CEO,Clix Capital Said," Our efforts along with Karnataka Bank will empower the MSME to fulfil their aspirations of seeking seamless &affordable business loans to grow.With this partnership,we will bring to the table our tech prowess,and agility to understand and underwrite segments that largely remain underserved".

Mr.Sekhar Rao,Executive Director,Karnataka Bank,said," the tie up shall leverage technology & digital solutions to seamlessly extend wide range of financial products to MSME sector".

Karnataka Bank is celebrating their centenary year this year.

APOLLO REVOLUTIONIZES PROSTATE CANCER SCREENING FOR INDIAN MEN WITH GROUNDBREAKING STUDY.

In a monumental stride towards advancing prostate cancer in India,Apollo Hospitals,the world's largest integrated health care provider,has unveiled ground breaking findings in its latest study,'Determining age-specific prostate -specific antigen for healthy Indian men" published in the prestigeous Indian Journal of urology led by DR.N,Raghavan and Dr.Sanjai Addla,from Apollo Chennai and Apollo,Hyderabad respectively.Thee study involved nearly 1,00,000 healthy men across diverse age groups and regions in India establishing new reference values for prostate specific antigen (PSA)specific to the Indian demographic.

        PSA is an established blood marker for early diagnosis and monitoring of treatment  for prostate cancer .Since 1993,International norms for normal PSA values have been based on a study from the USA and the same have been adopted in India.The western standards quiet often were found to be ill suited for the Indian population over to diverse genetic demarcations.This latest groundbreaking Apollo study reveals that PSA values in India differ,prompting the establishment of new tailored standards.Key findings include age specific  PSA standards,a progressive increase in PSA levels with age,and Indian specific PSA values facilitating earlier detection in younger men. 

Dr.Sangita Reddy,Joint Managing Director,Apollo Hospitals, said,"This landmark study ushers a transformative moment in India's prostate cancer care landscape,which resonates with our mission to conquer cancer at every touchpoint possible".

RAM MANDIR- GRAND INAUGURATION ON 22nd JANUARY,2024 AT AYODHYA.

 In the happiness of Ram Mandir Verdict, we would have forgotten the lawyer 92 year old then,now 96 years old Mr.K.Parasaran  who argued for the Ram Janma Bhoomi case in Supreme Court.  He is a Senior Supreme Court Lawyer  and his legal career spans over Six decades.He served as Attorney General of India between 1983 to 1989.He is considered as PITAMAH of Indian Bar. He was also nominated to Rajya Sabha from 2012 to 2018. His attendance in Rajya Sabha was 81% even at the age of 90.He was awarded Padma Bhushan & Padma Vibhushan.

He argued the Ram Janma Bhoomi  case in Supreme Court   bare foot standing for more than 4 hours at the age of 92 years. That was his faith towards Lord Ram. Even when the Judge requested him to take seat and continue the argument,he said he has argued all cases standing for his clients till date.Now,Lord himself is his client, How can I sit & argue ?,he said.

ASTER CMI HOSPITAL LAUNCHES HEART FAILURE CLINIC AND DAYCARE CENTRE.

 Aster CMI Hospital today launched Heart Failure Clinic and expanded cardiac expertise with a one of its kind Day Care facility for Heart failure management that will provide integrated medical services to heart failure patients.These units will reduce log term hospitalisation and minimise mortality and morbidity to the patients with  heart failure symptoms.Inaugurating the clinic, Mrs. Ashwini  Puneeth Rajkumar, renowned Kannda Film producer,

 
said,Heart related ailments are on the rise in India and there is immediate need for such dedicated clinics that can educate the public on do's and don'ts of healthy living, and the importance of regular screenings and early medical interventions".

"Specialised Clinics like this are proactive answers for heart failure patients and is a ' win-win situation for individuals & society" says Dr.Nagamalesh,U.M.Lead Consultant ,Cardiology, Interventional Cardiologist ,DirectorHeart Failure,Transplant & MCS clinic,Aster CMI Hospital,Bangalore.

Speaking at the launch  Mr.SGS Lakshmanan,COO,Aster CMI Hospital,Bangalore Said," The Heart Failure clinic & Day Care Facility is monitored by multi disciplinary experts and dedicated  Cardiologists. We have successfully conducted 9 Heart transplants in an impressively brief timeframe,thanks to our multi disciplinary team's collaborative approach "

FORUM SOUTH BANGALORE UNVEILS DAZZLING 50 FOOT SWAROVSKI'S TREE OF WONDER.

 Inspired by the success of the Swarovski  Christmas tree activation worldwide,this sparkling holiday season, Forum South announced the unveiling of Swarovski's spectacular "Tree Of Wonder".This Tree stands at an impressive 50 feet adorned with an unique design using the brand's iconic octagon shaped gift boxes.The Octagon, a symbol of rebirth,infinity and transition,holds special significance for Swarovski as it mirrors the brand's journey.Comprising eight facets,the Octagon effortlessly ties into the world of Swarovski,where facets are masterfully owned.The tree is composed of octagon shaped boxes,each radiating five distinct colours that define the brand's identity.These colours carry symbolic meanings,reflecting the essence of Swarovski.

1. Swan White: The essence of Swarovski,representing pure crystal.

2. Green : A serene hue embodying the natural world and the origin of Swarovski's products.

3.Baby blue; Symbolising water & energy driving forward thinking.

4.Yellow : Radiating positivity and warmth,the unapologetic & bold colour of the sun.

5. Pink : A welcoming and soft colour,expressing the genderless aesthetic of Swarovski.

Under the "Celebrate Wonder" Swarovski invites everyone to embrace the power of crystals,igniting self expression and providing an oppurtunity for everyone to shine during the holiday season.There will be slection of stellar gifts and mesmerizing adornments.There will be a guess and win contest with an array of exciting prizes that promises to bring joy for the entire festive season from now 
till the end of February,2024.

Mr.V.Muhammad Ali, CEO,Retail,Prestige Group said,"We are thrilled to join hands with Swarovski and feel privileged to present a special Christmas decor,curated exclusively for the vibrant Bangalore Audience".

About Forum South Bangalore : Forum south Bangalore Stands as the epitome of a premium shopping destination in Bangalore.As Prestige Group's largest retail venture,Forum South Bangalore spans over a million Square feet of space,housing selection of the finest international and domestic brands.Forum South Bangalore  completes One year.

ASTER CMI HOSPITAL TREATS 5 MONTH OLD CHILD WEIGHING LESS THAN 5 Kgs FROM A RARE CONGENITAL IMMUNE DISORDER -LEUKOCYTE ADHESION DEFICIENCY (LAD).

 LAD is a rare genetic disease that causes severe immuno deficiency which prevents the body's immune system from normal functioning.This makes children with LAD very susceptible to infections,which can be fatal. The only curative treatment for LAD is Bone Marrow Transplantation (BMT)from a healthy donor. Fortunately, the mother emerged as a beacon of  hope as she was human leukocyte antigen (HLA) compatible with the baby.

Addressing the Media,Dr.Anoop,P.Sr. Consultant-Haematology,Paediatric ,Haemato-Oncology &BMT,Aster CMI Hospital,said," due to Complications involved,most treatment centers even  in
affluent countries may prefer to perform BMT after a baby weighs 10 kgs and is completely free of active infection.The procedure was challenging ,however, our team went ahead with transplantation with cautious optimism.We are delighted that the procedure was successful,the infant is now recovering well,her immune system is healthy,and she is expected to lead a normal life."

The BMT was conducted along with the team of experts comprising of pediatric Haemato-Oncology  & BMT,Senior Consultants,Dr.Stalin Ramprakash, & Dr. Raghuram CP and Dr.Sagar Bhattad,Consultant- Paediatric Immunology  & Rheumatology played a crucial role in the early diagnosis of this disease and saved the baby's life.